10 Jefferies Group Dexcom Trades
Jefferies Group's position in Dexcom is currently worth $1.77 Million. That's 0.03% of their equity portfolio (392nd largest holding). The first Dexcom trade was made in Q4 2022. Since then Jefferies Group bought shares three more times and sold shares on six occasions. The investor's estimated purchase price is $2.17 Million, resulting in a loss of 19%.
News about Dexcom Inc and Jefferies Group
DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DXCM
LOS ANGELES , Sept. 5, 2024 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against DexCom, Inc. ("DexCom" or "the Company") (N...
Dexcom (DXCM) Faces Challenges Over GLP-1s’ Long-Term Effects on Its Target Market
The Ithaka Group, an investment advisory firm, released the “Ithaka US Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloa...
Mobile Healthcare Global Market Report 2022
Major players in the mobile healthcare market are Apple Inc. , Koninklijke Philips N. V, Omron Corporation, athenahealth Inc, iHealth Labs Inc. , AT&T, Samsu...
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi''s Pemphigus Trial Disappointment, Humanigen''s COVID-19 Drug Denied Emergency Use Authorization
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott La...